| Short Description : | Recombinant-SARS-COV-2 Spike S1-C-His-Avi protein was developed in expi293 using the region Gln14-Arg683. For use in research applications. |
| Host: | Expi293 |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Conjugation: | Biotin |
| Formulation: | Lyophilised from a 0.22 Mu m filtered solution of PBS, pH 7.4. |
| Storage Instruction: | Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Determination Method: | < 1 EU/Mu g of the protein by LAL method. |
| Immunogen: | Biotinylated Recombinant SARS-COV-2 SARS-COV-2 Spike S1 Protein is produced by Expi293 expression system. The target protein is expressed with sequence (Gln14-Arg683) of SARS-COV-2 SARS-COV-2 Spike S1 fused with His tag and Avi tag at the C-terminal. |
| Immunogen Region: | Gln14-Arg683 |